High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.

CONCLUSION: The expression of MALAT1 is upregulated in CRC tissues, and a higher expression level of MALAT1 might serve as a negative prognostic marker in stage II/III CRC patients. PMID: 25031737 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25031737?dopt=Abstract

Source: International Journal of Clinical and Experimental Pathology - July 19, 2014 Category: Pathology Authors: Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P, Gu WL, Cai GX, Cai SJ Tags: Int J Clin Exp Pathol Source Type: research